John Duan
Impact in
- Pharmaceutical Science top 2%
- Drug Solubulity and Delivery Systems
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
Papers in ⓘ
-
- Drug Solubulity and Delivery Systems 8
-
- Pharmacogenetics and Drug Metabolism 5
- Co-authors
- Jogarao Gobburu (4 shared papers)Richard Pazdur (2 shared papers)Martin H. Cohen (2 shared papers)John R. Johnson (2 shared papers)Kimberly Benson (2 shared papers)Rebecca Wood (1 shared paper)Atiqur Rahman (1 shared paper)Mark D. Rothmann (1 shared paper)
- Journals
- The AAPS Journal (6 papers)Journal of Pharmaceutical Sciences (2 papers)The Journal of Clinical Pharmacology (2 papers)Pharmaceutical Research (1 paper)CPT Pharmacometrics & Systems Pharmacology (1 paper)
- Partner nations
- United StatesThailandSpain
In The Last Decade
John Duan
23 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 109
- Pharmaceutical Science 183
- Hematology 252
- Genetics 184
- Statistics and Probability 130
- Pharmacology 134
Countries citing papers authored by John Duan
This map shows the geographic impact of John Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Duan more than expected).
Fields of papers citing papers by John Duan
This network shows the impact of papers produced by John Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Duan. The network helps show where John Duan may publish in the future.
Co-authors
The 25 scholars most cited alongside John Duan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. | 2002 | 387 |
| 2 | 2005 | 179 | |
| 3 | 2005 | 95 | |
| 4 | 2007 | 85 | |
| 5 | 2016 | 67 | |
| 6 | 1998 | 64 | |
| 7 | 2021 | 42 | |
| 8 | 2011 | 42 | |
| 9 | 2017 | 38 | |
| 10 | 2015 | 32 | |
| 11 | 2007 | 24 | |
| 12 | 2009 | 21 | |
| 13 | 2016 | 11 | |
| 14 | 2010 | 11 | |
| 15 | 1994 | 11 | |
| 16 | 2016 | 10 | |
| 17 | 2016 | 9 | |
| 18 | 2010 | 8 | |
| 19 | Reversal of doxorubicin resistance in multidrug resistant melanoma cells in vitro and in vivo by dipyridamole. | 1997 | 7 |
| 20 | 2020 | 4 |
About John Duan
John Duan is a scholar working on Pharmaceutical Science, Pharmacology, Analytical Chemistry, Statistics and Probability and Pediatrics, Perinatology and Child Health, having authored 23 papers that have together received 1.2k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (8 papers), Pharmaceutical studies and practices (7 papers), Pharmacogenetics and Drug Metabolism (5 papers), Analytical Methods in Pharmaceuticals (4 papers), Analytical Chemistry and Chromatography (3 papers), Statistical Methods in Clinical Trials (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Crystallization and Solubility Studies (3 papers). The work is most often cited by research in Pharmaceutical Science (183 citations), Hematology (252 citations), Genetics (184 citations), Statistics and Probability (130 citations) and Pharmacology (134 citations). John Duan has collaborated with scholars based in United States, Thailand and Spain. Frequent co-authors include Jogarao Gobburu, Richard Pazdur, Martin H. Cohen, John R. Johnson, Kimberly Benson, Rebecca Wood, Atiqur Rahman, Mark D. Rothmann, Gang Chen and Sung K. Kim. Their work appears in journals such as The AAPS Journal, Journal of Pharmaceutical Sciences, The Journal of Clinical Pharmacology, Pharmaceutical Research and CPT Pharmacometrics & Systems Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.